Dr. Michael J. Baine, MD

Dr. Baine practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Baine's NPI, 1043622764, was assigned on May 29, 2014. Dr. Baine graduated from University of Nebraska College of Medicine in 2014. Dr. Baine holds Nebraska license 31919.

Dr. Baine's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Baine also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Baine's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. Dr. Baine is also affiliated with Bellevue Medical Center. The medical group on file is UNMC Physicians. Dmand AI also links Dr. Baine to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baine practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Baine's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Baine is licensed in Nebraska.

CMS data shows 1,616 Medicare services from Dr. Baine across 12 procedure codes in 2024, for 263 Medicare patients. Medicare paid $122,155 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 263 Medicare patients who saw Dr. Baine in 2024. The largest group is 65 to 74, with 147 patients. 75% of them have cancer, and 72% have high blood pressure. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Baine's median patient age at 73, with 6% women.

In 2024, Dr. Baine wrote 179 Medicare Part D claims for 81 patients. 96% of them were for generic drugs. CMS names the drug for 141 of them, across 2 drugs with 11 or more claims each, at $2,746 in total drug cost. In 2023, CMS named 104 claims across 2 drugs.

Dr. Baine accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Baine as offering telehealth.

Dmand AI links 73 papers to Dr. Baine, published from 2010 to 2024. 2020 was the busiest year, with 13. The most frequent topics are Pancreatic Neoplasms, Lung Neoplasms and Radiosurgery. Dr. Baine has published most often in Cancers (Basel). Dr. Baine's most frequent co-authors are Chi Lin, MD, Surinder K. Batra, MD and Charles A. Enke, MD.

Dmand AI links Dr. Baine to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Urinary Bladder Neoplasms and Urinary Bladder Diseases.

CMS Open Payments shows 5 general payments to Dr. Baine from 5 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 78% of the total. Sanofi and Genzyme US Companies paid the most, $3,090.

Dr. Baine graduated from University of Nebraska College of Medicine in 2014.